The report predicts a 7% growth between 2024 and 2025 – with $180 million in estimated payments in 2024 and $193 million in 2025.
Colonoscopy and biopsy and colonoscopy with lesion removal are also slated for a 4% increase from 2024 to 2025.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.